The decision should be based on established indications, with any anti-inflammatory benefits considered as potential additional advantages rather than the main treatment goal
While necessary, this phase transforms toxins into "reactive intermediate metabolites" that are frequently more toxic and volatile than the original substance, generating massive amounts of free radicals
But heres the thing: women with PCOS often have a weaker GLP-1 response due to higher body fat, low muscle mass, and hormonal imbalances
How do we manage side effects
Given the scarcity of available evidence for the effects of T2D treatment on CV outcomes in women and the increased emphasis on CV risk reduction [2], additional analysis of CV outcome trials in T2D by gender could help individualize optimal care and risk management for all patients with a history of or risk factors for CVD
1A) and hyperintensity on T2WI images (Figs